{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:35:47Z","timestamp":1793504147324,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","award":["2015593"],"award-info":[{"award-number":["2015593"]}],"id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","award":["IN-US-987-5892"],"award-info":[{"award-number":["IN-US-987-5892"]}],"id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Americas"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.lana.2023.100648","type":"journal-article","created":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T19:11:58Z","timestamp":1702581118000},"page":"100648","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Implementation of a mobile health clinic framework for Hepatitis C virus screening and treatment: a descriptive study"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5275-7273","authenticated-orcid":false,"given":"Lior","family":"Rennert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry A.","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin M.","family":"Kickham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8287-2763","authenticated-orcid":false,"given":"Fatih","family":"Gezer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prerana","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristie","family":"Boswell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8185-4013","authenticated-orcid":false,"given":"Ronald W.","family":"Gimbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain H.","family":"Litwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lana.2023.100648_bib1","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1007\/s42399-020-00588-3","article-title":"Update on hepatitis C epidemiology: unaware and untreated infected population could be the key to elimination","volume":"2","author":"Stasi","year":"2020","journal-title":"SN Compr Clin Med"},{"key":"10.1016\/j.lana.2023.100648_bib2","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1001\/jama.2020.3693","article-title":"Updated CDC recommendations for universal hepatitis C virus screening among adults and pregnant women: implications for clinical practice","volume":"323","author":"Havens","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.lana.2023.100648_bib3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1478-3231.2011.02706.x","article-title":"Barriers to hepatitis C treatment","volume":"32","author":"McGowan","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.lana.2023.100648_bib4","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12939-017-0671-2","article-title":"The scope and impact of mobile health clinics in the United States: a literature review","volume":"16","author":"Yu","year":"2017","journal-title":"Int J Equity Health"},{"key":"10.1016\/j.lana.2023.100648_bib5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12939-020-1135-7","article-title":"Mobile health clinics in the United States","volume":"19","author":"Malone","year":"2020","journal-title":"Int J Equity Health"},{"key":"10.1016\/j.lana.2023.100648_bib6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.9745\/GHSP-D-14-00145","article-title":"Barriers to health care in rural Mozambique: a rapid ethnographic assessment of planned mobile health clinics for ART","volume":"3","author":"Schwitters","year":"2015","journal-title":"Glob Health Sci Pract"},{"key":"10.1016\/j.lana.2023.100648_bib7","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3928\/01913913-20150216-02","article-title":"The eagles eye mobile: assessing its ability to deliver eye care in a high-risk community","volume":"52","author":"Alvi","year":"2015","journal-title":"J\u00a0Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.lana.2023.100648_bib8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1353\/hpu.2010.0831","article-title":"Broadening perspectives on mobile medical outreach to homeless people","volume":"14","author":"Nuttbrock","year":"2003","journal-title":"J\u00a0Health Care Poor Underserved"},{"key":"10.1016\/j.lana.2023.100648_bib9","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.4269\/ajtmh.21-0199","article-title":"Ensuring COVID-19 vaccines for migrant and immigrant farmworkers","volume":"104","author":"Thomas","year":"2021","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.lana.2023.100648_bib10","doi-asserted-by":"crossref","first-page":"406","DOI":"10.2105\/AJPH.2011.300472","article-title":"Knowledgeable neighbors: a mobile clinic model for disease prevention and screening in underserved communities","volume":"102","author":"Hill","year":"2012","journal-title":"Am J Public Health"},{"key":"10.1016\/j.lana.2023.100648_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0256908","article-title":"From pandemic response to portable population health: a formative evaluation of the Detroit mobile health unit program","volume":"16","author":"Levy","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.lana.2023.100648_bib12","first-page":"922","article-title":"Strategies for hepatitis C testing and linkage to care for vulnerable populations: point-of-care and standard HCV testing in a mobile medical clinic","volume":"39","author":"Morano","year":"2014","journal-title":"J\u00a0Community Health"},{"key":"10.1016\/j.lana.2023.100648_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-039724","article-title":"The Copenhagen test and treat hepatitis C in a mobile clinic study: a protocol for an intervention study to enhance the HCV cascade of\u00a0care for people who inject drugs (T\u2019N\u2019T HepC)","volume":"10","author":"Lazarus","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.lana.2023.100648_bib14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3390\/vaccines10020211","article-title":"Meharry Medical College Mobile Vaccination program: implications for increasing COVID-19 vaccine uptake among minority communities in middle Tennessee","volume":"10","author":"Alcendor","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.lana.2023.100648_bib15","doi-asserted-by":"crossref","first-page":"879","DOI":"10.7326\/M22-0028","article-title":"Addressing inequities in SARS-CoV-2 vaccine uptake: the Boston Medical Center Health System experience","volume":"175","author":"Assoumou","year":"2022","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lana.2023.100648_bib16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1089\/tmj.2013.0080","article-title":"Mobile health is worth it! Economic benefit and impact on health of a population-based mobile screening program in New Mexico","volume":"20","author":"Brown-Connolly","year":"2014","journal-title":"Telemed J E Health"},{"key":"10.1016\/j.lana.2023.100648_bib17","article-title":"Using mobile clinics to deliver care to difficult-to-reach populations: a COVID-19 practice we should keep","volume":"24","author":"Leibowitz","year":"2021","journal-title":"Prev Med Rep"},{"key":"10.1016\/j.lana.2023.100648_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1741-7015-7-27","article-title":"Calculating the return on investment of mobile healthcare","volume":"7","author":"Oriol","year":"2009","journal-title":"BMC Med"},{"key":"10.1016\/j.lana.2023.100648_bib19","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1007\/s10620-018-5316-9","article-title":"Underserved does not mean undeserved: unfurling the HCV care in the safety net","volume":"63","author":"Khalili","year":"2018","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.lana.2023.100648_bib20","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/01.mcg.0000177258.95562.43","article-title":"High rates of uninsured among HCV-positive individuals","volume":"39","author":"Ong","year":"2005","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.lana.2023.100648_bib21","doi-asserted-by":"crossref","first-page":"413","DOI":"10.5604\/01.3001.0011.7385","article-title":"Direct acting antivirals improve HCV treatment initiation and adherence among underserved African Americans","volume":"17","author":"Beck","year":"2018","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.lana.2023.100648_bib22","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/COH.0000000000000179","article-title":"The hepatitis C virus epidemics in key populations (including people who inject drugs, prisoners and MSM): the use of direct-acting antivirals as treatment for prevention","volume":"10","author":"Martin","year":"2015","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.lana.2023.100648_bib23","doi-asserted-by":"crossref","first-page":"e309","DOI":"10.1016\/S2468-2667(21)00013-X","article-title":"Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis","volume":"6","author":"Arum","year":"2021","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.lana.2023.100648_bib24","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/liv.13949","article-title":"Hepatitis C elimination among people who inject drugs: challenges and recommendations for action within a health systems framework","volume":"39","author":"Day","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.lana.2023.100648_bib25","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1093\/cid\/cit263","article-title":"Understanding barriers to hepatitis C virus care and stigmatization from a social perspective","volume":"57","author":"Treloar","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lana.2023.100648_bib26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12954-021-00519-y","article-title":"Therapy of chronic hepatitis C in people who inject drugs: focus on adherence","volume":"18","author":"Frankova","year":"2021","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.lana.2023.100648_bib27","first-page":"126","article-title":"Limited uptake of hepatitis C treatment among injection drug users","volume":"33","author":"Mehta","year":"2007","journal-title":"J\u00a0Community Health"},{"key":"10.1016\/j.lana.2023.100648_bib28","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1007\/s10620-014-3416-8","article-title":"Utility of evaluating HCV in an uninsured population","volume":"60","author":"Donepudi","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.lana.2023.100648_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108553","article-title":"Mobile low-threshold buprenorphine integrated with infectious disease services","volume":"133","author":"Rosecrans","year":"2022","journal-title":"J\u00a0Subst Abuse Treat"},{"key":"10.1016\/j.lana.2023.100648_bib30","series-title":"When and in whom to initiate HCV therapy","year":"2022"},{"key":"10.1016\/j.lana.2023.100648_bib31","series-title":"HCV guidelines: recommendations for testing, managing, and treating hepatitis C","year":"2022"},{"key":"10.1016\/j.lana.2023.100648_bib32","doi-asserted-by":"crossref","DOI":"10.2196\/16863","article-title":"Decentralized, community-based hepatitis C point-of-care testing and direct-acting antiviral treatment for people who inject drugs and the general population in Myanmar: protocol for a feasibility study","volume":"9","author":"Draper","year":"2020","journal-title":"JMIR Res Protoc"},{"key":"10.1016\/j.lana.2023.100648_bib33","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-062745","article-title":"Patient outcomes in public sector hepatitis C treatment programmes: a retrospective cohort analysis across five low- and middle-income countries","volume":"12","author":"Boeke","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.lana.2023.100648_bib34","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/hep.27410","article-title":"Unrecognized chronic hepatitis C virus infection among baby boomers in the emergency department","volume":"61","author":"Galbraith","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.lana.2023.100648_bib35","first-page":"61","article-title":"Impact of hepatitis C virus and insurance coverage on mortality","volume":"25","author":"Bush","year":"2019","journal-title":"Am J Manage Care"},{"key":"10.1016\/j.lana.2023.100648_bib36","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/hep.24131","article-title":"Insurance status and treatment candidacy of hepatitis C patients: analysis of population-based data from the United States","volume":"53","author":"Stepanova","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.lana.2023.100648_bib37","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1111\/jvh.13574","article-title":"Global cascade of care for chronic hepatitis C virus infection: a systematic review and meta-analysis","volume":"28","author":"Yousafzai","year":"2021","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.lana.2023.100648_bib38","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/liv.14779","article-title":"Progress towards hepatitis C virus elimination in high-income countries: an updated analysis","volume":"41","author":"Gamkrelidze","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.lana.2023.100648_bib39","article-title":"Approaches for simplified HCV diagnostic algorithms","volume":"21","author":"Fourati","year":"2018","journal-title":"J\u00a0Int AIDS Soc"},{"key":"10.1016\/j.lana.2023.100648_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218759","article-title":"Initial uptake, time to treatment, and real-world effectiveness of all-oral direct-acting antivirals for hepatitis C virus infection in the United States: a retrospective cohort analysis","volume":"14","author":"Kwo","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.lana.2023.100648_bib41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/01974520-200504000-00002","article-title":"Health insurance, the uninsured, and hospitals: collision course","volume":"21","author":"Friedman","year":"2005","journal-title":"Front Health Serv Manag"},{"key":"10.1016\/j.lana.2023.100648_bib42","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/ajg.2015.31","article-title":"Lack of health insurance limits the benefits of hepatitis C virus screening: insights from the national health and nutrition examination hepatitis C follow-up study","volume":"110","author":"Ditah","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.lana.2023.100648_bib43","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/s41395-018-0033-8","article-title":"Race\/ethnicity and insurance status disparities in access to direct acting antivirals for hepatitis C virus treatment","volume":"113","author":"Wong","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.lana.2023.100648_bib44","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1016\/j.amepre.2022.03.010","article-title":"Medicaid hepatitis C virus treatment policies: impact on testing and treatment in the commercially insured","volume":"63","author":"Epstein","year":"2022","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.lana.2023.100648_bib45","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1478-3231.2011.02722.x","article-title":"Patient time costs and out-of-pocket costs in hepatitis C","volume":"32","author":"Federico","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.lana.2023.100648_bib46","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1353\/hpu.2021.0142","article-title":"Improving access to hepatitis C treatment using clinical pharmacist services in an uninsured, at-risk population at a community health center","volume":"32","author":"Fitzgerald","year":"2021","journal-title":"J\u00a0Health Care Poor Underserved"},{"key":"10.1016\/j.lana.2023.100648_bib47","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1148\/radiology.201.2.8888236","article-title":"Mobile mammography: results of a national survey","volume":"201","author":"DeBruhl","year":"1996","journal-title":"Radiology"},{"key":"10.1016\/j.lana.2023.100648_bib48","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1046\/j.1440-172x.2000.00221.x","article-title":"Migrant farm workers and their families: cultural patterns and delivery of care in the United States","volume":"6","author":"Bechtel","year":"2000","journal-title":"Int J Nurs Pract"}],"container-title":["The Lancet Regional Health - Americas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667193X23002223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667193X23002223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T22:56:14Z","timestamp":1762642574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667193X23002223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":48,"alternative-id":["S2667193X23002223"],"URL":"https:\/\/doi.org\/10.1016\/j.lana.2023.100648","relation":{},"ISSN":["2667-193X"],"issn-type":[{"value":"2667-193X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implementation of a mobile health clinic framework for Hepatitis C virus screening and treatment: a descriptive study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Americas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lana.2023.100648","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100648"}}